Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119138284 | 11913828 | 4 | F | 20151224 | 20160902 | 20160113 | 20160909 | EXP | JP-009507513-1601JPN002749 | MERCK | 74.00 | YR | M | Y | 63.00000 | KG | 20160909 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119138284 | 11913828 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | 800 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 61600 | MG | 20903 | 800 | MG | CAPSULE | QD | ||||
| 119138284 | 11913828 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG/ DAY, DIVIDED DOSE FREQUENCY UNKNOWN | 30800 | MG | 0 | 400 | MG | TABLET | QD | ||||
| 119138284 | 11913828 | 3 | C | SLO-BID | THEOPHYLLINE ANHYDROUS | 1 | Oral | 800 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 800 | MG | QD | |||||||
| 119138284 | 11913828 | 4 | C | ADOAIR | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | DAILY DOSAGE UNKNOWN | 0 | ||||||||||
| 119138284 | 11913828 | 5 | C | BEROTEC | FENOTEROL HYDROBROMIDE | 1 | Respiratory (inhalation) | DAILY DOSAGE UNKNOWN | 0 | ||||||||||
| 119138284 | 11913828 | 6 | C | AMLODIN (amlodipine besylate) | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 5 | MG | QD | |||||||
| 119138284 | 11913828 | 7 | C | OMEPRAL | OMEPRAZOLE | 1 | Oral | 20 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119138284 | 11913828 | 1 | Chronic hepatitis C |
| 119138284 | 11913828 | 2 | Chronic hepatitis C |
| 119138284 | 11913828 | 3 | Asthma |
| 119138284 | 11913828 | 4 | Asthma |
| 119138284 | 11913828 | 5 | Asthma |
| 119138284 | 11913828 | 6 | Hypertension |
| 119138284 | 11913828 | 7 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119138284 | 11913828 | OT |
| 119138284 | 11913828 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119138284 | 11913828 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119138284 | 11913828 | 1 | 20151009 | 20160101 | 0 | |
| 119138284 | 11913828 | 2 | 20151009 | 20160101 | 0 |